1. A perspective on the three large multicenter randomized clinical trials of coronary artery bypass surgery for unstable angina. Circulation 1985; 72(suppl V);Rahimtoola, S.H.G.
2. Reversible ischaemic left ventricular dysfunction; evidence for the "hibernating myocardium";Braunwald, E.; Rutherford, J.D.;_J Am Coil Cardiol,1986
3. Coronary thrombolysis with recombinant human tissue type plasminogen activator: a prospective randomized placebo-controlled trial;Collen, D.; Topol, E.J.; Tiefenbrunn, A.J.; Gold, H.K.; Weisfeldt, M.L.; Sobel, B.E.;Circulation,1984
4. A randomised placebocontrolled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarction;Topol, E.J.; O'Neil, W.W.; Langburd, A.B.; Walton, J.A.; Bourdillon, B.D.V.; Grines, C.L.;Circulation,1987
5. Beneficial effect of residual antegrade flow on tissue viability as assessed by positron emission tomography in patients with myocardial infarction;Schwaiger, M.; Brunken, R.C.; Krivokapich, J.; Child, S.; Tillisch, J.H.; Phelps, M.E.;Eur Heart J,1987